Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac energy levels in lean versus obese type 2 diabetes with liraglutide and pioglitazone crossover
ISRCTN85605342Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Mar 2020
- Modality
- Small Molecules, Peptides
01
Overview
A Phase 4 trial of liraglutide, pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by University of Leeds. Started Mar 2020; status: completed.
02
Drugs
liraglutidepioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN85605342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85605342.